---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-034961"
form_type: "8-K"
ticker: "PROK"
cik: "0001850270"
company_name: "PROKIDNEY CORP."
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T09:15:12.357526+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ProKidney FY2023 net loss $135.4M; cash $363M; positive Phase 2 data; mfg pause

## Summary
- Net loss before noncontrolling interest $135.4M vs $148.1M in 2022; cash $363.0M, funding into Q4 2025.
- R&D expenses $106.7M, up $24.6M on Phase 3 costs; G&A $44.8M, down $26.1M on lower equity comp.
- Appointed Dr. Bruce Culleton as CEO and Nikhil Pereira-Kamath as Chief Business Officer.
- Positive interim Phase 2 RMCL-002 data showed kidney function preservation; PROACT 1 enrollment modified to eGFR 20-35.
- Manufacturing paused for protocol amendment and QP audit; expects PROACT 1 and PROACT 2 enrollment to resume mid-2024.

## SEC filing metadata
- accession: 0000950170-24-034961
- form_type: 8-K
- ticker: PROK
- cik: 0001850270
- company_name: PROKIDNEY CORP.
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850270/000095017024034961/0000950170-24-034961-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850270/000095017024034961/prok-20240321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-034961
- JSON: https://secwatch.observer/filing/0000950170-24-034961.json
- Plain text: https://secwatch.observer/filing/0000950170-24-034961.txt

## Key facts
- Earnings Releases
  PROKIDNEY CORP. reported financial results for the year ended December 31, 2023.
  - Period: the year ended December 31, 2023
  - Result: reported results
  source text: ProKidney Corp. issued a press release to announce its financial results for the year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850270/000095017024034961/0000950170-24-034961-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.